John H Pulliam Jr, MD | |
200 E Evergreen St, Sherman, TX 75090-5056 | |
(903) 957-3230 | |
(903) 957-4046 |
Full Name | John H Pulliam Jr |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 39 Years |
Location | 200 E Evergreen St, Sherman, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710923388 | NPI | - | NPPES |
3284675 | Other | TX | BCBS |
140002115 | Other | TX | RR MEDICARE |
0451684-01 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | H0737 (Texas) | Primary |
207T00000X | Neurological Surgery | E-6727 (Arkansas) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott And White Surgical Hospital At Sherma | Sherman, TX | Hospital |
Entity Name | Frio Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952308132 PECOS PAC ID: 4981599693 Enrollment ID: O20040219000995 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
As recently as the Vietnam and Korean wars, soldiers' families commonly had to wait months to receive word from family members on the front lines. Now, cell phones and the internet allow deployed soldiers and their families to communicate instantly.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
› Verified 4 days ago
Entity Name | John H Pulliam Md Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477955565 PECOS PAC ID: 2567785975 Enrollment ID: O20141216000545 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
As recently as the Vietnam and Korean wars, soldiers' families commonly had to wait months to receive word from family members on the front lines. Now, cell phones and the internet allow deployed soldiers and their families to communicate instantly.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
› Verified 4 days ago
Entity Name | Frio Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215574959 PECOS PAC ID: 4981599693 Enrollment ID: O20200318000091 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
As recently as the Vietnam and Korean wars, soldiers' families commonly had to wait months to receive word from family members on the front lines. Now, cell phones and the internet allow deployed soldiers and their families to communicate instantly.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
John H Pulliam Jr, MD 200 E Evergreen St, Sherman, TX 75090-5056 Ph: (903) 957-3230 | John H Pulliam Jr, MD 200 E Evergreen St, Sherman, TX 75090-5056 Ph: (903) 957-3230 |
News Archive
Soligenix, Inc., a development stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to OrbeShield (oral beclomethasone 17,21-dipropionate or oral BDP) for the prevention of death following a potentially lethal dose of total body irradiation during or after a radiation disaster.
As recently as the Vietnam and Korean wars, soldiers' families commonly had to wait months to receive word from family members on the front lines. Now, cell phones and the internet allow deployed soldiers and their families to communicate instantly.
Affimed Therapeutics AG announced today further results from its phase 1 clinical trial of AFM13 as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma.
"The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account-Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems," IIP Digital reports.
› Verified 4 days ago
Abdul Abu Baker, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 E Taylor St Ste 308, Sherman, TX 75090 Phone: 469-947-7463 Fax: 903-416-6461 | |
Dr. David Bruce Ramsey, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 E. Taylor, Suite 3008, Sherman, TX 75090 Phone: 903-893-5177 Fax: 903-813-0210 | |
Mark Viktor Silver, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 N Highland Ave Ste 310, Sherman, TX 75092 Phone: 903-957-0003 Fax: 903-957-0007 |